Tzu Chi Medical Journal
Volume 20, Issue 3 , Pages 213-217, September 2008

Association Between Nonalcoholic Fatty Liver Disease and Cardiovascular Risk Factors in a Hospital-Based Study

  • Hsueh-Chou Lai

      Affiliations

    • Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan
    • ,
  • Tsann Lin

      Affiliations

    • Department of Family Medicine, China Medical University Hospital, Taichung, Taiwan
    • ,
  • Shih-Wei Lai

      Affiliations

    • Department of Family Medicine, China Medical University Hospital, Taichung, Taiwan
    • Corresponding Author InformationCorresponding author. Department of Family Medicine, China Medical University Hospital, 2, Yuh-Der Road, Taichung, Taiwan
    • ,
  • Kuan-Fu Liao

      Affiliations

    • Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan

Received 24 December 2007; received in revised form 4 January 2008; accepted 25 January 2008.

Article Outline

Abstract 

Objective

The objective of this study was to assess the association between nonalcoholic fatty liver disease (NAFLD) and cardiovascular risk factors.

Materials and Methods

This was a hospital-based, cross-sectional study. We retrospectively analyzed the medical records of all the people who received periodic health examinations at one medical center in Taichung, Taiwan from 2001 to 2004. Subjects with alcoholism and those who were positive for hepatitis B surface antigen and hepatitis C virus antibody were excluded. In all, 3488 subjects were included for further analysis. The t test, c2 test and multivariate logistic regression were used.

Results

There were 1766 men (50.6%) and 1722 women (49.4%). The mean age was 49.4 ± 12.4 years (range, 20–87 years). The overall prevalence of NAFLD was 46.9%, with significantly higher prevalence in men than in women (55.4% vs. 38.3%, p < 0.001). Multivariate logistic regression analysis showed that the factors that were significantly related to NAFLD were male gender (OR, 1.81), generalized obesity (OR, 2.94), central obesity (OR, 2.12), hyperglycemia (OR, 2.05), hypercholesterolemia (OR, 1.32), hypertriglyceridemia (OR, 2.22), high levels of low-density lipoprotein cholesterol (OR, 1.29), low levels of high-density lipoprotein cholesterol (OR, 1.53), and hyperuricemia (OR, 1.63).

Conclusion

We found that NAFLD is significantly related to cardiovascular risk factors and hyperuricemia.

Keywords:  Cardiovascular risk factors , Hyperuricemia , Nonalcoholic fatty liver disease , Obesity

No full text is available. To read the body of this article, please view the PDF online.

 

Back to Article Outline

References 

  1. Lonardo A , Bellini M , Tartoni P , Tondelli E . The bright liver syndrome. Prevalence and determinants of a “bright” liver echopattern . Ital J Gastroenterol Hepatol . 1997;29:351–356
  2. Kawai N , Kawai T , Kawai K . Ultrasonic and laboratory studies on fatty liver in whitecollar workers . Nippon Shokakibyo Gakkai Zasshi . 1995;92:1058–1065
  3. Ikai E , Ishizaki M , Suzuki Y , Ishida M , Noborizaka Y , Yamada Y . Association between hepatic steatosis, insulin resistance and hyperinsulinaemia as related to hypertension in alcohol consumers and obese people . J Hum Hypertens . 1995;9:101–105
  4. Tacikowski T , Milewski B , Dzieniszewski J , Rakoczy A , Klosiewicz-Latoszek L . Liver steatosis assessed by ultrasonographic examination in patients with hyperlipoproteinemia . Wiad Lek . 1994;47:725–730
  5. Al-Quorain A , Satti MB , al-Hamdan AR , et al.   Pattern of chronic liver disease in the eastern province of Saudi Arabia. A hospitalbased clinicopathological study . Trop Geogr Med . 1994;46:358–360
  6. O'Connor BJ , Kathamna B , Tavill AS . Nonalcoholic fatty liver (NASH syndrome) . Gastroenterologist . 1997;5:316–329
  7. Powell EE , Cooksley WG , Hanson R , Searle J , Halliday JW , Powell LW . The natural history of nonalcoholic steatohepatitis: a followup study of fortytwo patients for up to 21 years . Hepatology . 1990;11:74–80
  8. Assy N , Kaita K , Mymin D , Levy C , Rosser B , Minuk G . Fatty infiltration of liver in hyperlipidemic patients . Dig Dis Sci . 2000;45:1929–1934
  9. Wanless IR , Lentz JS . Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors . Hepatology . 1990;12:1106–1110
  10. Marceau P , Biron S , Hould FS , et al.   Liver pathology and the metabolic syndrome X in severe obesity . J Clin Endocrinol Metab . 1999;84:1513–1517
  11. Takeda T , Fujino A , Mizoue T , Kaji H . Relationship between fatty liver and coronary risk factors . Sangyo Eiseigaku Zasshi . 2000;42:24–28
  12. Knobler H , Schattner A , Zhornicki T , et al.   Fatty liver—an additional and treatable feature of the insulin resistance syndrome . QJM . 1999;92:73–79
  13. Umeki S , Hisamoto N , Hara Y . Study on background factors associated with impaired glucose tolerance and/or diabetes mellitus . Acta Endocrinol (Copenh) . 1989;120:729–734
  14. Cortez-Pinto H , Camilo ME , Baptista A , De Oliveira AG , De Moura MC . Non-alcoholic fatty liver: another feature of the metabolic syndrome? . Clin Nutr . 1999;18:353–358
  15. Lin DY , Sheen IS , Chiu CT . Clinical significance of ultrasonographic fatty liver in asymptomatics: analysis of 1040 checkup subjects . J Med Ultrasound . 1993;1:165–171
  16. Miccoli R , Ceraudo AM , Manfredi SG , Odoguardi L , Navalesi R . Atherogenic dyslipidemia, metabolic syndrome and cardiovascular risk . Cardiologia . 1999;44:885–899
  17. Aronow WS . Cardiac risk factors: still important in the elderly . Geriatrics . 1990;45:71–74 79-80
  18. Saggiani F , Pilati S , Targher G , Branzi P , Muggeo M , Bonora E . Serum uric acid and related factors in 500 hospitalized subjects . Metabolism . 1996;45:1557–1561
  19. Woo J , Swaminathan R , Cockram C , Lau E , Chan A . Association between serum uric acid and some cardiovascular risk factors in a Chinese population . Postgrad Med J . 1994;70:486–491
  20. Agamah ES , Srinivasan SR , Webber LS , Berenson GS . Serum uric acid and its relation to cardiovascular disease risk factors in children and young adults from a biracial community: the Bogalusa Heart Study . J Lab Clin Med . 1991;118:241–249
  21. Chen YL , Liao KF , Lai SW , Li TC . Epidemiology of metabolic syndrome—a hospitalbased study in Taichung . Mid Taiwan J Med . 2005;10:196–203
  22. Ho HY , Lai HC , Lai MM , et al.   Relationship between nonalcoholic fatty liver and the components of metabolic syndrome—a hospitalbased study . Mid Taiwan J Med . 2006;11:35–41
  23. Lai SW , Tan CC , Ng KC . Hepatic effects in hyperlipidemic patients . Mid Taiwan J Med . 2002;7:160–164
  24. Department of Health, Taiwan. Main Causes of Death in 2005. Taipei, Taiwan: Department of Health, March 18, 2007. Available from: http://www.doh.gov.tw/ufile/doc/causesofdeath.pdf
  25. Lin SC , Shih SC , Kao CR , Chou SY . Prevalence of antibodies to hepatitis C virus in patients with nonalcoholic fatty liver . Zhonghua Yi Xue Za Zhi (Taipei) . 1995;56:80–85
  26. Chang WY , Chen CJ , Lu SN , et al.   Relationship between fatty liver, alanine aminotransferase, HBsAg and hepatitis C virus . J Gastroenterol Hepatol . 1992;7:455–458
  27. Bureau of Health Promotion, Department of Health, Taiwan, January 13, 2008. Available from: http://www.bhp.doh.gov.tw/BHPnet/Portal/Them_Show.aspx?Subject=200712-250023&Class=2&No=200712250120
  28. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) . JAMA . 2001;285:2486–2497
  29. Friedwald WT , Levy RI , Fredrickson DS . Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge . Clin Chem . 1972;18:499–502
  30. Paccaud F , Schluter-Fasmeyer V , Wietlisbach V , Bovet P . Dyslipidemia and abdominal obesity: an assessment in three general populations . J Clin Epidemiol . 2000;53:393–400
  31. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus  . report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus . Diabetes Care . 2000;23:4–19
  32. Chobanian AV , Bakris GL , Black HR , et al.   The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report . JAMA . 2003;289:2560–2572
  33. Chen CH , Huang MH , Yang JC , et al.   Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of Taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults . J Clin Gastroenterol . 2006;40:745–752
  34. Amarapurkar D , Kamani P , Patel N , et al.   Prevalence of nonalcoholic fatty liver disease: population based study . Ann Hepatol . 2007;6:161–163
  35. Zelber-Sagi S , Nitzan-Kaluski D , Halpern Z , Oren R . Prevalence of primary nonalcoholic fatty liver disease in a populationbased study and its association with biochemical and anthropometric measures . Liver Int . 2006;26:856–863
  36. Brea A , Mosquera D , Martín E , Arizti A , Cordero JL , Ros E . Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a casecontrol study . Arterioscler Thromb Vasc Biol . 2005;25:1045–1050

PII: S1016-3190(08)60038-5

doi:10.1016/S1016-3190(08)60038-5

Tzu Chi Medical Journal
Volume 20, Issue 3 , Pages 213-217, September 2008

Article Tools